SRC and neoplasm: During tumor progression, Src activity becomes abnormally elevated, and because mutation activation or amplification of Src is very rare in human tumors, altered extrinsic control of Src phosphorylation by kinase or phosphatase may represent an important mechanism of Src upregulation.